Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemias

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1
Figure 2


  1. Algar E . A review of the Wilms' tumor 1 gene (WT1) and its role in hematopoiesis and leukemia. J Hematother Stem Cell Res 2002; 11: 589–599.

    CAS  Article  Google Scholar 

  2. Elmaagacli AH, Koldehoff M, Peceny R, Klein-Hitpass L, Ottinger H, Beelen DW et al. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. Haematologica 2005; 90: 326–334.

    CAS  PubMed  Google Scholar 

  3. Lapillonne H, Renneville A, Auvrignon A, Flamant C, Blaise A, Perot C et al. High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia. J Clin Oncol 2006; 24: 1507–1515.

    CAS  Article  Google Scholar 

  4. Rizzi M, Tschan MP, Britschgi C, Britschgi A, Hugli B, Grob TJ et al. The death-associated protein kinase 2 (DAPK2) is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells. J Leukoc Biol 2007; 81: 1599–1608.

    CAS  Article  Google Scholar 

  5. Svedberg H, Chylicki K, Baldetorp B, Rauscher III FJ, Gullberg U . Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program. Oncogene 1998; 16: 925–932.

    CAS  Article  Google Scholar 

  6. Sreeramaneni R, Chaudhry A, McMahon M, Sherr CJ, Inoue K . Ras–Raf–Arf signaling critically depends on the Dmp1 transcription factor. Mol Cell Biol 2005; 25: 220–232.

    CAS  Article  Google Scholar 

  7. Rauscher III FJ, Morris JF, Tournay OE, Cook DM, Curran T . Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 1990; 250: 1259–1262.

    CAS  Article  Google Scholar 

Download references


We thank A Britschgi for assistance in ChIP assays. This work was supported by grants from the Bernese Cancer League (to MPT), the Swiss National Foundation 3100A0-112385 (to AT and MFF) the Marlies-Schwegler Foundation and the Bernese Foundation of Cancer Research (to MFF and AT) the Werner and Hedy Berger-Janser Foundation of Cancer Research (to MFF and MPT), the National Institutes of Health DK49886 and AI49165 (to BET) and the Swedish Cancer Foundation (to UG). MPT, UG, BET, MFF and AT participated in designing the research and wrote the paper; MPT, UG and DS performed the research. All authors checked the final version of the manuscript.

Author information

Authors and Affiliations


Corresponding author

Correspondence to M P Tschan.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tschan, M., Gullberg, U., Shan, D. et al. The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemias. Leukemia 22, 1087–1090 (2008).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links